All About Multiple Sclerosis

More MS news articles for September 2003

Interrupted therapy: Stopping and switching of the beta-interferons prescribed for MS

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12939437&dopt=Abstract

Neurology. 2003 Aug 26;61(4):551-4
Tremlett HL, Oger J.
Division of Neurology, Department of Medicine, University of British Columbia, Vancouver Hospital and Health Sciences Center, Canada.

A retrospective chart review of patients in British Columbia with multiple sclerosis prescribed beta-interferon (IFNbeta) between 1995 and 2001 was carried out to investigate reasons for the interruption of therapy.

The highest proportion of interruptions (76/281; 27%) occurred in the first 6 months.

The single most common reason was perceived lack of efficacy, cited by 84 of 281 (30%).

Gender, disability, and disease duration were identified as factors influencing interruption of IFNbeta therapy.